Nexus Pharmaceuticals, Announces Launch of Potassium Chloride in Water for Injection
BIOTECHNOLOGY
Less than 1 min.Read

Nexus Pharmaceuticals Announces Launch of Potassium Chloride in Water for Injection

Nexus Pharmaceuticals announced the launch of Potassium Chloride in Water for Injection in 10mEq/100mL, 10mEq/50mL, and 20mEq/50mL Single-Dose IV bags.

“Nexus is proud to introduce Potassium Chloride IV Bags to our suite of products,” said Usman Ahmed, Chief Operating Officer of Nexus Pharmaceuticals. “As a critical product for patients, Potassium Chloride is consistently on shortage. We are proud to be a part of the solution to the drug shortage problem by removing obstacles for patient care.”

Nexus Pharmaceuticals’ Potassium Chloride in Water for Injection will be available in environmentally friendly cartons of 24 IV bags.

About Potassium Chloride in Water for Injection

Potassium Chloride in Water for Injection is a sterile, nonpyrogenic, highly concentrated, ready-to-use solution of Potassium Chloride, USP in Water for Injection, USP for electrolyte replenishment in a single-dose container for intravenous administration. Potassium Chloride Injection is indicated in the treatment of potassium deficiency states when oral replacement is not feasible.

For prescribing information, please see the following link.

SourceNexus Pharmaceuticals

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

0
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

0
“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

0
The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

0
Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

0
New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330